IBRX

ImmunityBio, Inc.NASDAQHealthcare

$7.30+2.24%ClosedMarket Cap: $7.51B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-26	D. Boral Capital	—	Buy	—
2026-03-04	Piper Sandler	—	Overweight	—
2026-02-23	D. Boral Capital	—	Buy	—
2026-02-23	HC Wainwright & Co.	—	Buy	—
2026-01-23	D. Boral Capital	—	Buy	—
2026-01-23	BTIG	—	Buy	—
2026-01-20	Piper Sandler	—	Overweight	—
2025-12-16	D. Boral Capital	—	Buy	—
2025-12-12	Jefferies	—	Buy	—
2025-11-13	D. Boral Capital	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-0.06	$484.2M	3
Sun Dec 31	$0.51	$1.21B	3
Mon Dec 31	$1.09	$2.18B	1
Tue Dec 31	$1.96	$3.69B	1